发明名称 |
COX-2 INHIBITORS AND DENDRITIC CELLS FOR USE IN THE TREATMENT OF CANCER. |
摘要 |
The present invention relates to a method and combination therapy useful in the treatment of cancer. More specifically, the invention relates to the use of COX-2 inhibitors in combination with a therapeutic dendritic cell vaccine for treating cancer. The COX-2 inhibitors of the present invention are believed to inhibit the enzymatic activity of prostaglandineE<SUB>2 </SUB>(PGE<SUB>2</SUB>); thereby preventing COX-2 overexpressing tumors from evading immune surveillance by antigen-specific cytotoxic T lymphocytes (CTLs). COX-2 inhibitors are believed to suppress PGE<SUB>2 </SUB>that COX-2 overexpressing glioma produce, allowing tumor-infiltrating DCs to polarize Th cells toward Th-subset-1 (Th1). |
申请公布号 |
EP1670513(A2) |
申请公布日期 |
2006.06.21 |
申请号 |
EP20040809859 |
申请日期 |
2004.10.05 |
申请人 |
CEDARS-SINAI MEDICAL CENTER |
发明人 |
YU, JOHN, S.;AKASAKI, YASUHARU |
分类号 |
A61K45/06;A61K31/415;A61K35/14;A61K39/00;A61K45/00;A61K47/00;A61P35/00;C12N;(IPC1-7):A61K45/00 |
主分类号 |
A61K45/06 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|